Global Buprofezin
Market Report
2024
The global Bio Buprofezin market size will be USD 761.5 million in 2024. Increasing regulatory emphasis on environmentally sustainable pest control methods is expected to boost sales to USD 1107.7 million by 2031, with a Compound Annual Growth Rate (CAGR) of 5.50% from 2024 to 2031.
The base year for the calculation is 2023 and 2019 to 2023 will be historical period. The year 2024 will be estimated one while the forecasted data will be from year 2025 to 2031. When we deliver the report that time we updated report data till the purchase date.
PDF Access: Password protected PDF file, Excel File Access: Quantitative data, PPT Report Access: For the presentation purpose, Cloud Access: Secure Company Account Access.
Share your contact details to receive free updated sample copy/pages of the recently published edition of Buprofezin Market Report 2024.
According to Cognitive Market Research, the global Buprofezin market size will be USD 761.5 million in 2024. It will expand at a compound annual growth rate (CAGR) of 5.50% from 2024 to 2031.
Base Year | 2023 |
Historical Data Time Period | 2019-2023 |
Forecast Period | 2024-2031 |
Global Buprofezin Market Sales Revenue 2024 | $ 761.5 Million |
Global Buprofezin Market Compound Annual Growth Rate (CAGR) for 2024 to 2031 | 5.5% |
North America Buprofezin Sales Revenue 2024 | $ 304.6 Million |
North America Buprofezin Compound Annual Growth Rate (CAGR) for 2024 to 2031 | 3.7% |
United States Buprofezin Sales Revenue 2024 | $ 240.33 Million |
United States Buprofezin Compound Annual Growth Rate (CAGR) for 2024 to 2031 | 3.5% |
Canada Buprofezin Sales Revenue 2024 | $ 36.55 Million |
Canada Buprofezin Compound Annual Growth Rate (CAGR) for 2024 to 2031 | 4.5% |
Mexico Buprofezin Sales Revenue 2024 | $ 27.72 Million |
Mexico Buprofezin Compound Annual Growth Rate (CAGR) for 2024 to 2031 | 4.2% |
Europe Buprofezin Sales Revenue 2024 | $ 228.45 Million |
Europe Buprofezin Compound Annual Growth Rate (CAGR) for 2024 to 2031 | 4% |
United Kingdom Buprofezin Sales Revenue 2024 | $ 38.38 Million |
United Kingdom Buprofezin Compound Annual Growth Rate (CAGR) for 2024 to 2031 | 4.8% |
France Buprofezin Sales Revenue 2024 | $ 21.02 Million |
France Buprofezin Compound Annual Growth Rate (CAGR) for 2024 to 2031 | 3.2% |
Germany Buprofezin Sales Revenue 2024 | $ 45.23 Million |
Germany Buprofezin Compound Annual Growth Rate (CAGR) for 2024 to 2031 | 4.2% |
Italy Buprofezin Sales Revenue 2024 | $ 19.65 Million |
Italy Buprofezin Compound Annual Growth Rate (CAGR) for 2024 to 2031 | 3.4% |
Russia Buprofezin Sales Revenue 2024 | $ 35.41 Million |
Russia Buprofezin Compound Annual Growth Rate (CAGR) for 2024 to 2031 | 3% |
Spain Buprofezin Sales Revenue 2024 | $ 18.73 Million |
Spain Buprofezin Compound Annual Growth Rate (CAGR) for 2024 to 2031 | 3.1% |
Rest of Europe Buprofezin Sales Revenue 2024 | $ 35.41 Million |
Rest of Europe Buprofezin Compound Annual Growth Rate (CAGR) for 2024 to 2031 | 2.7% |
Asia Pacific Buprofezin Sales Revenue 2024 | $ 175.15 Million |
Asia Pacific Buprofezin Compound Annual Growth Rate (CAGR) for 2024 to 2031 | 7.5% |
China Buprofezin Sales Revenue 2024 | $ 78.82 Million |
China Buprofezin Compound Annual Growth Rate (CAGR) for 2024 to 2031 | 7% |
Japan Buprofezin Sales Revenue 2024 | $ 24.17 Million |
Japan Buprofezin Compound Annual Growth Rate (CAGR) for 2024 to 2031 | 6% |
Korea Buprofezin Sales Revenue 2024 | $ 17.51 Million |
Korea Buprofezin Compound Annual Growth Rate (CAGR) for 2024 to 2031 | 6.6% |
India Buprofezin Sales Revenue 2024 | $ 21.02 Million |
India Buprofezin Compound Annual Growth Rate (CAGR) for 2024 to 2031 | 9.3% |
Australia Buprofezin Sales Revenue 2024 | $ 9.11 Million |
Australia Buprofezin Compound Annual Growth Rate (CAGR) for 2024 to 2031 | 7.2% |
Rest of APAC Buprofezin Sales Revenue 2024 | $ 12.44 Million |
Rest of APAC Buprofezin Compound Annual Growth Rate (CAGR) for 2024 to 2031 | 7.3% |
South America Buprofezin Sales Revenue 2024 | $ 38.08 Million |
South America Buprofezin Compound Annual Growth Rate (CAGR) for 2024 to 2031 | 4.9% |
Brazil Buprofezin Sales Revenue 2024 | $ 16.3 Million |
Brazil Buprofezin Compound Annual Growth Rate (CAGR) for 2024 to 2031 | 5.5% |
Argentina Buprofezin Sales Revenue 2024 | $ 6.4 Million |
Argentina Buprofezin Compound Annual Growth Rate (CAGR) for 2024 to 2031 | 5.8% |
Colombia Buprofezin Sales Revenue 2024 | $ 3.39 Million |
Colombia Buprofezin Compound Annual Growth Rate (CAGR) for 2024 to 2031 | 4.7% |
Peru Buprofezin Sales Revenue 2024 | $ 3.12 Million |
Peru Buprofezin Compound Annual Growth Rate (CAGR) for 2024 to 2031 | 5.1% |
Chile Buprofezin Sales Revenue 2024 | $ 2.74 Million |
Chile Buprofezin Compound Annual Growth Rate (CAGR) for 2024 to 2031 | 5.2% |
Rest of South America Buprofezin Sales Revenue 2024 | $ 6.13 Million |
Rest of South America Buprofezin Compound Annual Growth Rate (CAGR) for 2024 to 2031 | 4% |
Middle East and Africa Buprofezin Sales Revenue 2024 | $ 15.23 Million |
Middle East and Africa Buprofezin Compound Annual Growth Rate (CAGR) for 2024 to 2031 | 5.2% |
Turkey Buprofezin Sales Revenue 2024 | $ 1.31 Million |
Turkey Buprofezin Compound Annual Growth Rate (CAGR) for 2024 to 2031 | 4.7% |
Nigeria Buprofezin Sales Revenue 2024 | $ 1.6 Million |
Nigeria Buprofezin Compound Annual Growth Rate (CAGR) for 2024 to 2031 | 4.3% |
Egypt Buprofezin Sales Revenue 2024 | $ 1.6 Million |
Egypt Buprofezin Compound Annual Growth Rate (CAGR) for 2024 to 2031 | 5.5% |
South Africa Buprofezin Sales Revenue 2024 | $ 2.41 Million |
South Africa Buprofezin Compound Annual Growth Rate (CAGR) for 2024 to 2031 | 6.2% |
GCC Countries Buprofezin Sales Revenue 2024 | $ 6.52 Million |
GCC Countries Buprofezin Compound Annual Growth Rate (CAGR) for 2024 to 2031 | 6% |
Rest of MEA Buprofezin Sales Revenue 2024 | $ 1.8 Million |
Rest of MEA Buprofezin Compound Annual Growth Rate (CAGR) for 2024 to 2031 | 4.2% |
Market Drivers:
| |
Market Restrains:
| |
Market Trends:
|
Market Split by formulation Outlook: |
|
Market Split by Crop type Outlook: |
|
Market Split by Pest Outlook: |
|
List of Competitors |
|
Regional Analysis |
|
Country Analysis |
|
Key Qualitative Information Covered |
|
Report scope is customizable as we have a huge database of Buprofezin industry. We can deliver an exclusive report Edition/Consultation as per your data requirements. Request for your Free Sample Pages.
Buprofezin Market is Segmented as below. Particular segment of your interest can be provided without any additional cost. Download the Sample Pages!
Buprofezin is a commonly used insecticide in agriculture to control pests such as mealybugs, whiteflies, and leafhoppers. It does this by inhibiting chitin biosynthesis during molting, which results in immature death. This chemical is essential for integrated pest management (IPM) programs because of its targeted action and minimal impact on beneficial insects and mammals. Advancements in agricultural practices, the necessity for effective pest control solutions, and the growing recognition of sustainable farming methods are the primary factors driving the buprofezin market. The demand for buprofezin is on the rise, fueled by government initiatives and investments in the agricultural sector, as the prevalence of pest-related crop damage increases and global food demand continues to rise. The Expansion of High-Value Crop Cultivation The demand for buprofezin is driven by the growing cultivation of high-value crops, including fruits, vegetables, and ornamentals. Effective pest control measures are essential due to the economic value of these crops, which are particularly susceptible to pest infestations. Buprofezin's capacity to safeguard these high-value crops from insect damage has made it a preferred choice among growers, which has further fueled market growth.
In May 2022, In an all-cash transaction valued at approximately USD 197.5 million, Albaugh, LLC announced the acquisition of Rotam AgroSciences Limited. The merger will establish a global leader in crop protection with revenues that surpass $2 billion. The merged entity will capitalize on a diverse product line, robust manufacturing bases in numerous regions, and improved research and development capabilities. The acquisition is anticipated to be finalized upon the receipt of regulatory clearances and approval from Rotam's general shareholders meeting. Cash, existing credit facilities, and incremental debt will be utilized to finance the transaction. The objective of the merger is to capitalize on the strengths of both organizations in order to offer innovative solutions to farmers worldwide.
(Source: https://www.albaugh.com/global-articles/news/detail/2022/05/02/albaugh-to-acquire-rotam)
In order to improve food production and sustainability, governments worldwide are making substantial investments in agricultural initiatives. For example, the Canadian government made substantial investments in the Canadian Agri-Food Sustainability Initiative. A strong commitment to sustainable agriculture is also evident in European initiatives such as the Common Agricultural Policy (CAP) and Young Farmers programs. The objectives of these initiatives are to enhance the methods of food production, promote green economy innovations, and increase the level of domestic organic production and consumption. In the United States alone, the substantial economic losses caused by pests and pathogens, which amount to nearly $40 billion annually, emphasize the necessity of effective agricultural chemicals. An insecticide that targets pests such as mealybugs and leafhoppers, buprofezin, is essential for combating these threats. It is a valuable tool for integrated pest management due to its growth inhibitor properties, which are driving its market growth as governments prioritize sustainable and effective agricultural practices.
The increasing prevalence of pests and diseases presents a substantial challenge for farmers, necessitating the implementation of effective pest control measures. Buprofezin, an insecticidal compound, combats this issue by targeting a wide range of pests, such as aphids, whiteflies, and thrips. Its significance in integrated pest management (IPM) programs, which are designed to mitigate environmental damage and decrease dependence on synthetic pesticides, is widely acknowledged. The demand for buprofezin is anticipated to be stimulated by the implementation of IPM practices. Additionally, buprofezin's market growth is further supported by the growing awareness among farmers of its advantages, including its minimal impact on beneficial insects and its efficacy against target pests. The buprofezin market is expected to experience moderate growth during the forecast period due to the increasing prevalence of pests and diseases associated with crops.
Although ibuprofen is effective in suppressing chitin biosynthesis during moulting and causing immature death in pests, its comprehensive mode of action remains unclear. The chemical's detrimental effects on marine life and non-target species are significant concerns. For example, the environmental and ecological concerns are heightened by buprofezin's toxicity to marine organisms and beneficial insects, such as bees. This has resulted in its prohibition in numerous countries, which has restricted its market accessibility. Additionally, the ecological risks associated with the disruption of reproductive processes in treated adult females, such as oviposition and egg fertility, are significant. These factors collectively contribute to a growing resistance against the use of buprofezin, highlighting the necessity of more sustainable and eco-friendly alternatives in pest control. The market expansion of buprofezin is further challenged by the ongoing efforts of environmental advocacy groups and regulatory bodies to implement stricter regulations and safer pest management solutions.
The buprofezin market was significantly affected by the COVID-19 pandemic. Delays in the production and distribution of agricultural chemicals, such as buprofezin, were caused by disruptions in global supply chains and restrictions on movement. The pandemic-induced economic downturn led to a decrease in spending by agricultural businesses and farmers, which in turn impacted demand. Nevertheless, the pandemic also underscored the significance of food security and effective pest control in order to guarantee crop yields, which helped alleviate some of the negative effects. The market was further bolstered by the necessity to maintain food production during the pandemic and the increased government support for agriculture. Buprofezin's relevance in the agricultural sector was maintained by its essential role in managing pests and ensuring crop health, despite the challenges it faced.
We have various report editions of Buprofezin Market, hence please contact our sales team and author directly to obtain/purchase a desired Edition eg, Global Edition, Regional Edition, Country Specific Report Edition, Company Profiles, Forecast Edition, etc. Request for your Free Sample PDF/Online Access.
In the Buprofezin market's competitive landscape, numerous key competitors are driving innovation and growth. Market rivalry is encouraging technological and design innovations to create Buprofezins that fulfill both consumer wants and sustainability goals, keeping the market dynamic and competitive.
In July 2023, Solus Biotech was acquired by Croda International Plc after South Korean regulatory approval. The deal, which was announced in February 2023 and is valued at KRW 350bn (£232m), grants Croda access to Solus' biotech-derived ceramide, phospholipid technologies, and natural retinol capabilities. This acquisition expands Croda's Asian manufacturing, enhances the Beauty Actives portfolio, and establishes a new biotechnology R&D hub. Croda's global formulation capabilities and market reach will be advantageous to Solus Biotech, a pioneer in the development of premium biotechnology-derived active ingredients for pharmaceuticals and beauty care.
(Source: https://www.croda.com/en-gb/media-hub/news/acquisitions-and-partners/acquisition-of-solus-biotech-expands-fast-growth-beauty-actives-business-in-asia)
In August 2022, Sumitomo Chemical Co., Ltd. has announced that its Board of Directors has approved the absorption of its wholly-owned subsidiary, SCIOCS COMPANY LIMITED, through an absorption-type merger, effective October 1, 2022. The objective of this merger is to expedite the growth of emerging businesses in the environment, food, healthcare, and ICT sectors. The merger will consolidate resources to improve the production and development capabilities of compound semiconductor materials. Sumitomo Chemical Group is anticipated to promote focused investment and global operations through this streamlined structure, which will remain unchanged in terms of its trade name, address, or business scope following the merger.
(Source: https://www.sumitomo-chem.co.jp/english/news/files/docs/20220801e_4.pdf)
Top Companies Market Share in Buprofezin Industry: (In no particular order of Rank)
If any Company(ies) of your interest has/have not been disclosed in the above list then please let us know the same so that we will check the data availability in our database and provide you the confirmation or include it in the final deliverables.
According to Cognitive Market Research, North America currently dominates the Buprofezin market, and the region is expected to have significant growth during the anticipated period. The adoption of integrated pest management (IPM) practices and the increasing demand for crop protection solutions are key growth drivers as a result of the increasing prevalence of pests.
Asia-Pacific is expected to make significant gains during the anticipated period, with the greatest compound annual growth rate (CAGR). The demand for effective pest management solutions is driven by the necessity for high crop yields, particularly in rice cultivation and extensive agricultural activities.
The current report Scope analyzes Buprofezin Market on 5 major region Split (In case you wish to acquire a specific region edition (more granular data) or any country Edition data then please write us on info@cognitivemarketresearch.com
The above graph is for illustrative purposes only.
To learn more about geographical trends request the free sample pages.
Get Free Sample
According to Cognitive Market Research, the global Buprofezin market size was estimated at USD 761.5 Million, out of which North America held the major market share of more than 40% of the global revenue with a market size of USD 304.60 million in 2024 and will grow at a compound annual growth rate (CAGR) of 3.7% from 2024 to 2031.
According to Cognitive Market Research, the global Buprofezin market size was estimated at USD 761.5 Million, out of which Europe held the market share of more than 30% of the global revenue with a market size of USD 228.45 million in 2024 and will grow at a compound annual growth rate (CAGR) of 4.0% from 2024 to 2031.
According to Cognitive Market Research, the global Buprofezin market size was estimated at USD 761.5 Million, out of which Asia Pacific held the market share of around 23% of the global revenue with a market size of USD 175.15 million in 2024 and will grow at a compound annual growth rate (CAGR) of 7.5% from 2024 to 2031.
According to Cognitive Market Research, the global Buprofezin market size was estimated at USD 761.5 Million, out of which the Latin America held the market share of around 5% of the global revenue with a market size of USD 38.08 million in 2024 and will grow at a compound annual growth rate (CAGR) of 4.9% from 2024 to 2031.
According to Cognitive Market Research, the global Buprofezin market size was estimated at USD 761.5 Million, out of which the Middle East and Africa held the major market share of around 2% of the global revenue with a market size of USD 15.23 million in 2024 and will grow at a compound annual growth rate (CAGR) of 5.2% from 2024 to 2031..
Global Buprofezin Market Report 2024 Edition talks about crucial market insights with the help of segments and sub-segments analysis. In this section, we reveal an in-depth analysis of the key factors influencing Buprofezin Industry growth. Buprofezin market has been segmented with the help of its formulation Outlook:, Crop type Outlook: Pest Outlook:, and others. Buprofezin market analysis helps to understand key industry segments, and their global, regional, and country-level insights. Furthermore, this analysis also provides information pertaining to segments that are going to be most lucrative in the near future and their expected growth rate and future market opportunities. The report also provides detailed insights into factors responsible for the positive or negative growth of each industry segment.
How are Segments Performing in the Global Buprofezin Market?
According to Cognitive Market Research, Wettable Powder is likely to dominate the Buprofezin Market over the projected period. This is due to its long-standing market presence, efficacy, and simplicity of use. The formulation is favoured by farmers due to its ease of mixing with water and application using standard sprinkling equipment, rendering it a convenient and efficient insect control solution.
The Drift Less Formulation is the fastest-growing segment in the Buprofezin Market. Propelled by the growing need for environmentally favourable and precise application methods that mitigate off-target effects and reduce environmental impact. With minimal dispersal, this formulation guarantees that the pesticide reaches its intended target, rendering it the preferable option for sustainable pest management measures.
The above Chart is for representative purposes and does not depict actual sale statistics. Access/Request the quantitative data to understand the trends and dominating segment of Buprofezin Industry. Request a Free Sample PDF!
According to Cognitive Market Research, the Cereals and Grains segment holds the largest share of the market. This is predominantly attributable to the widespread utilization of buprofezin in the cultivation of rice, a staple commodity in numerous regions. Buprofezin is the preferred option for farmers due to its efficacy in managing parasites such as planthoppers, which guarantees high crop yields and quality.
In the Buprofezin Market, the Fruits and Vegetables sector has been expanding at a rapid pace. The growth of this segment is driven by the growing demand for high-quality fruits and vegetables, as well as the necessity for effective pest management solutions. Buprofezin is an optimal choice for safeguarding a diverse array of fruits and vegetables due to its selective action against pests and minimal impact on beneficial insects.
The above Graph is for representation purposes only. This chart does not depict actual Market share.
To learn more about market share request the free sample pages.
Get Free Sample
According to Cognitive Market Research, The Planthoppers segment holds the largest market share. This is predominantly attributable to the extensive infestation of planthoppers in significant agricultural commodities, including soybeans, maize, and rice. Planthoppers are renowned for their detrimental grazing behaviours, which can significantly reduce crop yields.
In the Buprofezin market, the rapidly growing sector is the Scales category. This rapid expansion can be attributed to the increasing awareness among farmers of the efficacy of buprofezin in managing scale insects, which are notorious for causing substantial damage to a diverse array of commodities, such as fruits, vegetables, and ornamental plants.
Research Analyst at Cognitive Market Research
I am a well-organized, conscientious, and professional Research Analyst with two plus years of experience. In my current role, I conduct in-depth secondary research, data mining, competitive analysis, DRO's, PR, and Collateral writing. Whilst I enjoy working as part of a team, researching information, analyzing data, and producing results that help my organization to achieve its commercial and financial objectives.
Nisha Deore is a highly skilled Research Analyst with over three years of experience specializing in the agriculture and food & beverage sectors. Her expertise encompasses secondary research, data mining, competitive analysis, and the development of detailed collateral and PR materials. Known for her meticulous approach, Nisha designs robust research methodologies and delivers actionable insights that support her organization’s commercial and financial objectives.
In her current role, Nisha manages research for both the agriculture and food & beverage categories, leading initiatives to uncover market opportunities and enhance competitive positioning. Her strong analytical skills and ability to provide clear, impactful findings have been crucial to her team’s success. With a deep passion for both sectors and a commitment to continuous professional development, Nisha remains an invaluable asset in the dynamic landscape of market research.
Conclusion
Please note, we have not disclose, all the sources consulted/referred during a market study due to confidentiality and paid service concern. However, rest assured that upon purchasing the service or paid report version, we will release the comprehensive list of sources along with the complete report and we also provide the data support where you can intract with the team of analysts who worked on the report.
Disclaimer:
formulation Outlook: | Wettable powder, Emulsifiable concentrate, Water dispersible granules, Suspension concentrate, Drift less formulation, Others |
Crop type Outlook: | Cereals and grains, Fruits and vegetables, Others |
Pest Outlook: | Planthoppers, Nephotettix and nilaparvata & thrips, Nilaparvata and sogatella, Scales, Others |
List of Competitors | Albaugh LLC, Anmol Biotech Private Limited, Aristo Bio-tech And Lifescience Limited, Bayer AG, Bharat Group, Biostadt India Limited, Canary Agro Chemicals Private Limited, Croda International PLC, Dhanuka Agritech Limited, Hebei Enge Biotech Co. Ltd., Insecticides (India) Limited, Jaffer Group, Jaivik Crop Care LLP, Kenvos AG, King Quenson Group, Merck KGaA, Nihon Nohyaku Co. Ltd., Nova Agritech Limited, Paras Crops Limited, Parijat Industries India Pvt. Ltd., Rallis India Limited by Tata Chemicals Limited, Sumitomo Chemical Co. Ltd.., Thermo Fisher Scientific Inc., UPL Ltd., Zagro |
This chapter will help you gain GLOBAL Market Analysis of Buprofezin. Further deep in this chapter, you will be able to review Global Buprofezin Market Split by various segments and Geographical Split.
Chapter 1 Global Market Analysis
Global Market has been segmented on the basis 5 major regions such as North America, Europe, Asia-Pacific, Middle East & Africa, and Latin America.
You can purchase only the Executive Summary of Global Market (2019 vs 2024 vs 2031)
Global Market Dynamics, Trends, Drivers, Restraints, Opportunities, Only Pointers will be deliverable
Chapter 2 North America Market Analysis
Chapter 3 Europe Market Analysis
Chapter 4 Asia Pacific Market Analysis
Chapter 5 South America Market Analysis
Chapter 6 Middle East and Africa Market Analysis
Only Available with Corporate User License
Chapter 7 Top 10 Countries Analysis (Only Available with Corporate User License)
Competitor's Market Share and Revenue (Subject to Data Availability for Private Players)
Chapter 8 Competitor Analysis (Subject to Data Availability (Private Players))
(Subject to Data Availability (Private Players))
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
Chapter 9 Qualitative Analysis (Subject to Data Availability)
Segmentation formulation Outlook: Analysis 2019 -2031, will provide market size split by formulation Outlook:. This Information is provided at Global Level, Regional Level and Top Countries Level The report with the segmentation perspective mentioned under this chapters will be delivered to you On Demand. So please let us know if you would like to receive this additional data as well. No additional cost will be applicable for the same.
Chapter 10 Market Split by formulation Outlook: Analysis 2019 -2031
The report with the segmentation perspective mentioned under this chapters will be delivered to you On Demand. So please let us know if you would like to receive this additional data as well. No additional cost will be applicable for the same.
Chapter 11 Market Split by Crop type Outlook: Analysis 2019 -2031
The report with the segmentation perspective mentioned under this chapters will be delivered to you On Demand. So please let us know if you would like to receive this additional data as well. No additional cost will be applicable for the same.
Chapter 12 Market Split by Pest Outlook: Analysis 2019 -2031
This chapter helps you understand the Key Takeaways and Analyst Point of View of the global Buprofezin market
Chapter 13 Research Findings
Here the analyst will summarize the content of entire report and will share his view point on the current industry scenario and how the market is expected to perform in the near future. The points shared by the analyst are based on his/her detailed in-depth understanding of the market during the course of this report study. You will be provided exclusive rights to interact with the concerned analyst for unlimited time pre purchase as well as post purchase of the report.
Why Wettable powder have a significant impact on Buprofezin market? |
What are the key factors affecting the Wettable powder and Emulsifiable concentrate of Buprofezin Market? |
What is the CAGR/Growth Rate of Cereals and grains during the forecast period? |
By type, which segment accounted for largest share of the global Buprofezin Market? |
Which region is expected to dominate the global Buprofezin Market within the forecast period? |
Segmentation Level Customization |
|
Global level Data Customization |
|
Region level Data Customization |
|
Country level Data Customization |
|
Company Level |
|
Additional Data Analysis |
|
Additional Qualitative Data |
|
Additional Quantitative Data |
|
Service Level Customization |
|
Report Format Alteration |
|
Published Report Editions
are Just a Tip of an Iceberg
Access the Complete Database of
Buprofezin Market
Request Sample